These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 825589)

  • 21. Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.
    Tally FP; Louie TJ; Weinstein WM; Bartlett JG; Gorbach SL
    Ann Intern Med; 1975 Oct; 83(4):484-8. PubMed ID: 1101761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kinetics of multiple-dose amikacin in the newborn infant].
    Olivesi A; Camboulives J; Charrel C; Unal D
    Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amikacin in treatment of infections caused by gram-negative bacteria resistant to gentamicin and other aminoglycosides: clinical and bacteriologic results.
    Daikos GK; Kosmidis JC; Hamilton-Miller JM; Brumfitt W
    J Infect Dis; 1976 Nov; 134 SUPPL():S286-90. PubMed ID: 993623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of amikacin in infants and pre-school children.
    Kafetzis DA; Sinaniotis CA; Papadatos CJ; Kosmidis J
    Acta Paediatr Scand; 1979 May; 68(3):419-22. PubMed ID: 443042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
    Mita T; Mayumi K; Kataoka N; Ishigami J
    Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447
    [No Abstract]   [Full Text] [Related]  

  • 26. An overview of pediatric experience with amikacin.
    Yow MD
    Am J Med; 1977 Jun; 62(6):954-8. PubMed ID: 868913
    [No Abstract]   [Full Text] [Related]  

  • 27. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.
    Klastersky J; Hensgens C; Meunier-Carpentier F
    J Infect Dis; 1976 Nov; 134 SUPPL():S433-40. PubMed ID: 792359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of amikacin in patients with impaired renal function.
    McHenry MC; Wagner JG; Hall PM; Vidt DG; Gavan TL
    J Infect Dis; 1976 Nov; 134 SUPPL():S343-8. PubMed ID: 993627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amikacin in newborn infants: comparative pharmacology with kanamycin and clinical efficacy in 45 neonates with bacterial diseases.
    Howard JB; McCraken GH; Trujillo H; Mohs E
    Antimicrob Agents Chemother; 1976 Aug; 10(2):205-10. PubMed ID: 984762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)].
    Hotta T; Hirabayashi N; Shimizu K; Utsumi M; Katoh T; Maeda H; Hirano A; Ohnishi K; Murate T; Yamada H
    Jpn J Antibiot; 1981 Nov; 34(11):1457-64. PubMed ID: 7334580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-course aminoglycoside therapy in patients with spinal cord injury. Standard dose versus low dose.
    Sapico FL; Lindquist LB; Montgomerie JZ; Jimenez EM; Morrow JW
    Urology; 1980 May; 15(5):457-60. PubMed ID: 6763394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
    Feld R; Valdivieso M; Bodey GP; Rodriguez V
    J Infect Dis; 1977 Jan; 135(1):61-6. PubMed ID: 401853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].
    Federspil P; Schindler K; Weich C; Tiesler E; Schätzle W; Ziegler M
    Infection; 1979; 7(2):81-7. PubMed ID: 374277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hospita-acquired infections with amikacin.
    Doughty SC; Martin RR; Greenberg SB
    Am J Med; 1977 Jun; 62(6):889-93. PubMed ID: 868903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amikacin pharmacokinetics in pediatric patients with malignancy.
    Cleary TG; Pickering LK; Kramer WG; Culbert S; Frankel LS; Kohl S
    Antimicrob Agents Chemother; 1979 Dec; 16(6):829-32. PubMed ID: 533263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amikacin (BBK8) in infections due to gram-negative organisms in children over the age of one month.
    Ramirez JI; Trujillo H; Uribe A; Agudelo NH; de Vidal EL
    J Int Med Res; 1976; 4(1):1-14. PubMed ID: 1026522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function.
    Tofte RW; Canafax DM; Simmons RL; Peterson PK
    Ann Surg; 1982 Mar; 195(3):287-93. PubMed ID: 7036923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The combination therapy of amikacin and beta-lactam antibiotic in the severe bacterial infections (author's transl)].
    Takigami T
    Jpn J Antibiot; 1982 Feb; 35(2):369-74. PubMed ID: 7087174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Amikacin resistance of clinical strains of Enterobacteriaceae and Pseudomonas].
    Moreva TV; Anisimova LA; Erova TE; Boronin AM
    Antibiot Khimioter; 1992 Apr; 37(4):25-8. PubMed ID: 1417311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.